Cargando…

Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern

The ongoing coronavirus disease 2019 (COVID-19) pandemic continues to disrupt essential health services in 90 percent of countries today. The spike (S) protein found on the surface of the causative agent, the SARS-CoV-2 virus, has been the prime target for current vaccine research since antibodies d...

Descripción completa

Detalles Bibliográficos
Autores principales:	McMillan, Christopher L. D., Azuar, Armira, Choo, Jovin J. Y., Modhiran, Naphak, Amarilla, Alberto A., Isaacs, Ariel, Honeyman, Kate E., Cheung, Stacey T. M., Liang, Benjamin, Wurm, Maria J., Pino, Paco, Kint, Joeri, Fernando, Germain J. P., Landsberg, Michael J., Khromykh, Alexander A., Hobson-Peters, Jody, Watterson, Daniel, Young, Paul R., Muller, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030474/ https://www.ncbi.nlm.nih.gov/pubmed/35455326 http://dx.doi.org/10.3390/vaccines10040578

Ejemplares similares

Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern
por: McMillan, Christopher L.D., et al.
Publicado: (2022)

Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine
por: McMillan, Christopher L. D., et al.
Publicado: (2021)

Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay
por: Shalash, Ahmed O., et al.
Publicado: (2021)

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Inactivation of SARS‐CoV‐2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light
por: Hobson‐Peters, Jody, et al.
Publicado: (2023)

The distinguishing NS5-M114V mutation in American Zika virus isolates has negligible impacts on virus replication and transmission potential
por: Peng, Nias Y. G., et al.
Publicado: (2022)

Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern
por: Morgan, Mahali S., et al.
Publicado: (2022)

SARS‐CoV‐2 triggers complement activation through interactions with heparan sulfate
por: Lo, Martin W, et al.
Publicado: (2022)

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants
por: Isaacs, Ariel, et al.
Publicado: (2022)

Implications of Dengue Virus Maturation on Vaccine Induced Humoral Immunity in Mice
por: Scott, Connor A. P., et al.
Publicado: (2021)

The structure of an infectious immature flavivirus redefines viral architecture and maturation
por: Newton, Natalee D., et al.
Publicado: (2021)

An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2
por: Amarilla, Alberto A., et al.
Publicado: (2021)

No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing
por: Smits, Nathan, et al.
Publicado: (2021)

Rapid Response Subunit Vaccine Design in the Absence of Structural Information
por: Wijesundara, Danushka K., et al.
Publicado: (2020)

ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
por: Rawle, Daniel J., et al.
Publicado: (2021)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2
por: Albert, Simon, et al.
Publicado: (2021)

A unified route for flavivirus structures uncovers essential pocket factors conserved across pathogenic viruses
por: Hardy, Joshua M., et al.
Publicado: (2021)

Affordable SARS-CoV-2 protein vaccines for the pandemic endgame
por: Triccas, James A., et al.
Publicado: (2022)

Reporter Flaviviruses as Tools to Demonstrate Homologous and Heterologous Superinfection Exclusion
por: Torres, Francisco J., et al.
Publicado: (2022)

Structure and antigenicity of divergent Henipavirus fusion glycoproteins
por: Isaacs, Ariel, et al.
Publicado: (2023)

Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates
por: Isaacs, Ariel, et al.
Publicado: (2021)

Developing a Stabilizing Formulation of a Live Chimeric Dengue Virus Vaccine Dry Coated on a High-Density Microarray Patch
por: Choo, Jovin J. Y., et al.
Publicado: (2021)

A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice
por: Choo, Jovin J. Y., et al.
Publicado: (2021)

Subversion of Innate Defenses by the Interplay between DENV and Pre-Existing Enhancing Antibodies: TLRs Signaling Collapse
por: Modhiran, Naphak, et al.
Publicado: (2010)

Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
por: McMillan, Christopher L. D., et al.
Publicado: (2021)

Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
por: McMillan, Christopher L. D., et al.
Publicado: (2022)

A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
por: Amarilla, Alberto A., et al.
Publicado: (2021)

Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2019)

Quantification of Interferon Signaling in Avian Cells
por: Kint, Joeri, et al.
Publicado: (2014)

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
por: Albornoz, Eduardo A., et al.
Publicado: (2022)

Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell–cell fusion
por: Thakur, Nazia, et al.
Publicado: (2020)

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens
por: Counoupas, Claudio, et al.
Publicado: (2022)

Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus
por: Yang, Jieru, et al.
Publicado: (2021)

Quantification of Infectious Bronchitis Coronavirus by Titration In Vitro and In Ovo
por: Kint, Joeri, et al.
Publicado: (2014)

Intra-host diversities of the receptor-binding domain of stork faeces-derived avian H5N1 viruses and its significance as predicted by molecular dynamic simulation
por: Ubol, Sukathida, et al.
Publicado: (2011)

A platform technology for generating subunit vaccines against diverse viral pathogens
por: Young, Andrew, et al.
Publicado: (2022)

Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
por: Chappell, Keith J., et al.
Publicado: (2023)

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
por: Valenzuela Nieto, Guillermo, et al.
Publicado: (2021)

Viral RNA Intermediates as Targets for Detection and Discovery of Novel and Emerging Mosquito-Borne Viruses
por: O’Brien, Caitlin A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o3u0uqtk52f2qdrpfs8p3vn50q